Oruka Therapeutics, Inc.
ORKA
Kedudukan dalam Saham
#3289
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses... Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.
Harga Saham
$81.40
Modal Pasaran
$5.39B
Perubahan (1 hari)
1.86%
Perubahan (1 tahun)
205.46%
Negara
US
Perdagangan Oruka Therapeutics, Inc. (ORKA)
Kategori
Healthcare
Nisbah P/B bagi Oruka Therapeutics, Inc. (ORKA)
Nisbah P/B pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Oruka Therapeutics, Inc., nisbah P/B semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/B syarikat ialah 0.
Sejarah nisbah P/B untuk Oruka Therapeutics, Inc. dari 2005 hingga 2026
Nisbah P/B pada akhir setiap tahun
| Tahun | Nisbah P/B | Ubah |
|---|---|---|
| 2025 | 2.93 | 243.97% |
| 2024 | 0.85 | -89.28% |
| 2023 | 7.94 | -19.22% |
| 2022 | 9.83 | 39.93% |
| 2021 | 7.03 | 44.25% |
| 2020 | 4.87 | 391.44% |
| 2019 | 0.99 | 30.86% |
| 2018 | 0.76 | -44.72% |
| 2017 | 1.37 | 17.70% |
| 2016 | 1.16 | 51.58% |
| 2015 | 0.77 | -41.86% |
| 2014 | 1.32 | 42.00% |
| 2013 | 0.93 | -46.63% |
| 2012 | 1.74 | -0.42% |
| 2011 | 1.75 | -56.04% |
| 2010 | 3.98 | 27.67% |
| 2009 | 3.12 | -7,157.47% |
| 2008 | -0.04 | -103.06% |
| 2007 | 1.44 | -51.05% |
| 2006 | 2.95 | -50.04% |
| 2005 | 5.90 | 0.00% |
Nisbah P/B untuk syarikat atau pesaing yang serupa
| Syarikat | Nisbah P/B | Perbezaan Nisbah P/B | Negara |
|---|---|---|---|
| 6.251 | - |
US
|
|
| 13.2547 | - |
US
|
|
| 4.4521 | - |
AU
|
|
| 6.3632 | - |
NL
|
|
| 3.2932 | - |
BE
|
